| |
Other studies have not found similar results but may have been flawed. Hydrazine sulfate is usually administered orally to cancer patients in 60mg capsules or tablets, approximately one to two hours before meals. It is given at first once per day for several days, then twice, then three or four times daily, depending on the patient's response and the physician's judgment. Approximately half of the patients to whom the drug is properly administered in the early stages of the disease show an almost immediate weight gain and reversal of symptoms; in some instances, the tumor eventually disappears. The common types of cancer most frequently reported to benefit from hydrazine sulfate therapy are recto-colon cancer, ovarian cancer, prostatic cancer, lung (bronchogenic) cancer, Hodgkin's disease and other lymphomas, thyroid cancer, melanoma, and breast cancer.
|
|
|
